Clinical Trials Browser

Phase 1/2 × Esophageal Neoplasms × Radiotherapy, Intensity-Modulated × Clear all

NCT03991104 2023-09-21

SOX-based CRT for Esophageal Cancer.

Phase 1/2 Withdrawn

Gastrointestinal

Esophageal Neoplasms